Sanofi to Buy Synthorx for $2.5 Billion

The video discusses several business deals and market strategies. Sanofi's acquisition in the biotech sector is seen as a beneficial move. The food delivery market in Berlin is experiencing a bidding war, particularly involving Just Eat. Tesco is reviewing its profitable Asian business for potential sale to focus on restructuring in the UK. Lastly, AMS has finally secured shareholder approval for its acquisition of Osram after a lengthy process.

What is the main reason Sanofi is paying a 170% premium in the biotech sector?

• To reduce competition

• To grow further in the biotech space

• To diversify its portfolio

• To enter a new market

What is the current situation in the Berlin food delivery market?

• There is a bidding war involving Just Eat

• Food delivery options are increasing

• A new company is entering the market

• Just Eat is exiting the market

Which companies are involved in the bidding war for Just Eat?

• Amazon and Alibaba

• Grubhub and DoorDash

• Process and Takeaway.com

• Uber Eats and Deliveroo

Why is Tesco considering selling its Asian business?

• To focus on online sales

• To enter the US market

• To expand in Asia

• To fund UK restructuring efforts

What was a significant challenge in the AMS-Osram deal?

• Regulatory issues

• Multiple bid retractions

• Lack of shareholder approval

• Competition from other bidders